Lungpacer Medical

Lungpacer Medical is developing a new treatment to protect the integrity and strength of the diaphragm. The company aims to develop and commercialize a new therapy to address significant health and cost issues related to mechanical ventilation in critically ill patients in hospital intensive care units (ICUs). The solution is expected to use a temporary, minimally invasive, transvascular nerve stimulation method to activate the diaphragm, which is anticipated to save many lives, improve patient outcomes, and significantly reduce hospital care costs.